J.P. Morgan AM launches thematic fund on genetic therapies

Europe
On the 11.14.19 at 11:19AM

by

Laurence Marchal

The JPMorgan Funds - Thematics - Genetic Therapies fund combines machine learning capabilities and equity specialist convictions.
DNA
(Pixabay)

J.P Morgan AM's new strategy relies on research driven by chief investment officer of UBS Wealth Management. Swiss group UBS will start the initial distribution of the fund.

Sign in

Get free Access

Get free Access

Agefi Event

Tuesday, 10 December 2019
Frankfurt

AFTER BREXIT, CONTINENTAL FINANCE WILL AFFIRM ITS MODEL